Meeting of The Research, Development, and Regulatory Roundtable (R3) - The Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard

The use for clinical trial recruitment purposes of data that were originally collected for another business purpose raises several legal and regulatory questions, including whether health care providers may receive payment for permitting secondary uses of their data, the extent to which third-party payors, or agents of those payors, may be involved in research recruitment, and which entities may contact patients directly to discuss possible enrollment in a clinical trial. During this session, roundtable participants discussed each of these issues from a legal and regulatory perspective, noting the many issues for which there is legal ambiguity.

The R3 meeting took place on Thursday, March 7, from 10:00am – 3:00pm at the Washington, D.C. offices of Ropes & Gray LLP.

For more information, please email at MRCT@BWH.HARVARD.EDU

Deliverables